51 related articles for article (PubMed ID: 36201928)
1. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract][Full Text] [Related]
2. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological and molecular genetic characteristics of ELOC mutated renal cell carcinoma].
Wen Z; Zhang WH; Liang JY; Chai J; Wang YM; Xu WN; Wang Z; Fan LN
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1204-1209. PubMed ID: 38058035
[No Abstract] [Full Text] [Related]
4. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract][Full Text] [Related]
5. [Expression of programmed cell death ligand 1 and clinicopathological and immunological characteristics in fumarate hydratase-deficient renal cell carcinoma].
Chen S; Ban CR; Zhang XT; Chen YP; Ren CH; Chen H
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):155-161. PubMed ID: 38281783
[No Abstract] [Full Text] [Related]
6. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
7. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological and molecular features of metaplastic thymoma].
Wang X; Zhang RS; Li R; Ye SB; Li Q; Chen H; Xia QY; Wu N; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1237-1243. PubMed ID: 38058040
[No Abstract] [Full Text] [Related]
9. Hereditary papillary renal cell carcinoma.
Jacoba IM; Lu Z
Semin Diagn Pathol; 2024 Jan; 41(1):28-31. PubMed ID: 38135585
[TBL] [Abstract][Full Text] [Related]
10. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
[TBL] [Abstract][Full Text] [Related]
12. Aggressive renal cell carcinoma with biphasic papillary and solid clear cell features harboring IDH2 (R172M) mutation.
Zhao M; Xia Y; Wang W
Pathol Res Pract; 2024 Jan; 253():155090. PubMed ID: 38181579
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological, Immunohistochemical, and Molecular Characteristics of Pigmented Microcystic Chromophobe Renal Cell Carcinoma with Favorable Prognosis.
Guo X; Xiao Z; Xu H; Ren K; Li X; Wu YK; Liu Y; Zhou L; Wang L; Liu H; Dong L; Dong H; Yang X
Int J Surg Pathol; 2024 Jan; ():10668969231217632. PubMed ID: 38173283
[No Abstract] [Full Text] [Related]
14. Primary retroperitoneal renal cell carcinoma associated with transcription EB gene fusion.
Liu Z; Hua X
Minerva Med; 2024 Feb; 115(1):32-36. PubMed ID: 32239878
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells.
Bielecka ZF; Malinowska A; Brodaczewska KK; Klemba A; Kieda C; Krasowski P; Grzesiuk E; Piwowarski J; Czarnecka AM; Szczylik C
Cell Biosci; 2017; 7():71. PubMed ID: 29270287
[TBL] [Abstract][Full Text] [Related]
16. [Primary pulmonary NUT carcinoma: a clinicopathological analysis of seven cases].
Zhuang XP; Huang HJ; Chen X; Zheng SL; Li BC; Sun H
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1244-1248. PubMed ID: 38058041
[No Abstract] [Full Text] [Related]
17. Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
[TBL] [Abstract][Full Text] [Related]
18. Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations.
Zhang Y; Zhou Z; Liu X; Zhu L; Cui Y; Li TJ; Zhou CX
Am J Surg Pathol; 2024 Mar; 48(3):266-274. PubMed ID: 38050369
[TBL] [Abstract][Full Text] [Related]
19. GLI1-altered Mesenchymal Tumor Involving the Duodenum: Case Report and Literature Review.
Zeng Y; Yao H; Jiang X; Tang X; Wang X
Int J Surg Pathol; 2023 Dec; 31(8):1538-1547. PubMed ID: 36855297
[TBL] [Abstract][Full Text] [Related]
20. Warthin-like papillary renal cell carcinoma: A case report.
Li XF; Wang ZJ; Zhang HM; Yang MQ
World J Clin Cases; 2023 Oct; 11(30):7450-7456. PubMed ID: 37969440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
